EPCAM and neoplasm: The images of tumors at the end of treatment are shown in Figure 6E. There was significant reduction in tumor size and weight in the EpCAM-CD3 hFc mRNA-LNP and T cell–treated group versus the PBS and GFP mRNA-LNP–treated group.